about
Megestrol acetate inhibits the expression of cytoplasmic aromatase through nuclear C/EBPβ in reperfusion injury-induced ischemic rat hippocampusAltered mechanisms of motor-evoked potential generation after transient focal cerebral ischemia in the rat: implications for transcranial magnetic stimulation.Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: a cautionary note.Hydrogen peroxide-induced stroke: elucidation of the mechanism in vivo.Cortical spreading depression activates and upregulates MMP-9.Thrombotic distal middle cerebral artery occlusion produced by topical FeCl(3) application: a novel model suitable for intravital microscopy and thrombolysis studies.Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]alpha-synuclein transgenic mouseSystemically administered brain-targeted nanoparticles transport peptides across the blood-brain barrier and provide neuroprotection.The Presence of Autoantibodies Against Vascular and Nervous Tissue in Sera From Patients with Neuro-Behçet's Disease.Microvascular protection is essential for successful neuroprotection in stroke.The role of Pericytes in Neurovascular Unit: Emphasis on Stroke.Optical coherence tomography imaging of capillary reperfusion after ischemic stroke.Reversible transverse sinus collapse in a patient with idiopathic intracranial hypertension.Data of indirect immunofluorescence labeling of the mouse brain sections with sera from SLE and MS patients.The time course changes in expression of aquaporin 4 and aquaporin 1 following global cerebral ischemic edema in rat.A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection.Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery.Persistent defect in transmitter release and synapsin phosphorylation in cerebral cortex after transient moderate ischemic injury.A new model of transient focal cerebral ischemia for inducing selective neuronal necrosis.Astrocytes are more resistant to focal cerebral ischemia than neurons and die by a delayed necrosis.Inadequate Brain Glycogen or Sleep Increases Spreading Depression Susceptibility.Microembolism of single cortical arterioles can induce spreading depression and ischemic injury; a potential trigger for migraine and related MRI lesions.A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles.Spreading Depolarization Waves in Neurological Diseases: A Short Review about its Pathophysiology and Clinical Relevance.Behçet Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger.Poloxamer-188 and citicoline provide neuronal membrane integrity and protect membrane stability in cortical spreading depression.Plasma 3-nitrotyrosine estimates the reperfusion-induced cerebrovascular stress, whereas matrix metalloproteinases mainly reflect plasma activity: a study in patients treated with thrombolysis or endovascular recanalization.Transport of a caspase inhibitor across the blood-brain barrier by chitosan nanoparticles.Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options.Re: "Report of Dramatic Improvement after a Lumboperitoneal Shunt Procedure in a Case of Anticoagulation Therapy-Resistant Cerebral Venous Thrombosis".Atypical Aicardi-Goutieres syndrome: is the WRN locus a modifier?VEGF protects brain against focal ischemia without increasing blood--brain permeability when administered intracerebroventricularlyChanges in the expression of selenoproteins in mesial temporal lobe epilepsy patients
P50
Q28580449-5275B2EB-D247-46C3-836A-45F714C9835BQ30890352-B9FD032F-82A7-4CAC-A8F5-8CAA493C894DQ33204310-7AC89AD1-38CD-4E1D-8C8F-9A4F91338EC1Q33377553-43D84D4D-AF84-4414-AAA1-9E7C3803F83CQ33785624-BBEA2401-A062-4E52-8AA2-B3281B4FE974Q33821930-1C2577C3-33B6-4CFC-AD9D-D16DF0CE413AQ34714740-A26D296B-944A-4DE9-B382-EBDEB74C16CAQ35143516-4B5C5A44-B12A-4997-9377-4EBE3F1D9A39Q37703882-8EDF0A5C-6ACF-4264-919F-D0B2CBA94651Q38050820-F71D0029-53DC-4D1C-B19B-A8FE0508D43FQ38863756-3C1AECE5-6061-49EE-9FE0-E54AF611A6F8Q39168799-4A1F21F1-E5D8-4E7A-85F5-6B421BD8D9CFQ40751260-F1709481-C8E3-4F3F-BF68-BB1DD614CA5BQ42373483-6CD8D275-14B4-415C-89C4-0B54A1A8BB55Q43074392-6488FFC5-BA14-4121-BEF2-A4C54137FF0EQ43248430-0A9A4875-5F81-46D0-8D22-9BE95D13EFB9Q43283511-64940343-38BC-45A6-B7F8-740DADA1026BQ43978713-BCA56311-C79C-4194-9AF9-29A7503C42D4Q46209821-D4E0550F-7CE9-45D3-9BFC-A2DA85D23B25Q46300646-7C900D6C-8ADB-453A-959E-9BD48F0E6CB7Q47653689-72587877-EEDD-4E9B-A3E8-1DAD35F4E395Q47693554-6683133E-70CD-4221-82CE-D5F00BB4E866Q47707316-79B9D640-0621-4678-9B71-3C22527CF0E0Q47765191-3568E015-49B5-431B-AE4E-D1BE16D1D0B1Q47899285-677DFDB9-5B08-401C-BFFF-6664964CF358Q48187119-A287D501-A182-497B-AED4-5E1D6541F0B7Q48324705-107A1A90-590F-4BF8-A5B7-37FF9A63C3E5Q48597089-7BA5C2C5-0D62-458C-95FC-BB884AA03EDBQ52670226-8D5D2413-EAC5-408E-899E-9521FA7EBD97Q53791452-DB14522F-6372-465D-A8E7-C4AEFE0A494AQ57755320-867E9205-4380-4893-A7B7-24FC4C6C1C3AQ81649097-22105DD6-4ADF-4F42-8A87-9E12C8B23633Q84007969-F1FC6FCF-6D0A-4645-AA2A-173D9EA799EE
P50
description
researcher
@en
name
Y Gürsoy-Ozdemir
@en
Y Gürsoy-Ozdemir
@nl
type
label
Y Gürsoy-Ozdemir
@en
Y Gürsoy-Ozdemir
@nl
prefLabel
Y Gürsoy-Ozdemir
@en
Y Gürsoy-Ozdemir
@nl
P106
P31
P496
0000-0002-0860-8964